A Cancer Vaccine?

Another very interesting and promising development in the world of cancer treatment.  Vaxil Bio Therapeutics, a biotechnology company in Israel, has created a vaccine with the potential to prevent the recurrence of 90% of cancers.  The vaccine is in clinical trials at Hadassah University Medical Center in Jerusalem and is being administered to patients with multiple myeloma.  The new vaccine works by “training” T-cells to search for and destroy cells with the MUC-1 molecule, typically only found in cancer cells.  Read about this encouraging development at http://ireport.cnn.com/docs/DOC-732256.

Speak Your Mind

*